Clinical Trial

Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This is a Phase 1/2 study to evaluate the safety and clinical activity of ENP-501 in non-peanut allergic (NPA) healthy participants and participants with an established peanut allergy (PA)
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-04; most recent amendment 2026-04-23.
Status change: Not Yet Recruiting → Recruiting 2026-04-23
Trial Details
NCT Number NCT07117669
Lead Sponsor N-Fold, LLC
Collaborators: CBCC Global Research
Conditions Peanut Allergy
Enrollment 68 participants
Start Date 2025-12-16
Primary Completion 2028-11 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-04-24